Published on in Vol 8, No 2 (2022): Apr-Jun

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/34833, first published .
Investigation of Intervention Solutions to Enhance Adherence to Oral Anticancer Medicines in Adults: Overview of Reviews

Investigation of Intervention Solutions to Enhance Adherence to Oral Anticancer Medicines in Adults: Overview of Reviews

Investigation of Intervention Solutions to Enhance Adherence to Oral Anticancer Medicines in Adults: Overview of Reviews

Journals

  1. Khurana R, Li C, Lum F. Loss to Follow-up in Patients with Neovascular Age-Related Macular Degeneration Treated with Anti–VEGF Therapy in the United States in the IRIS® Registry. Ophthalmology 2023;130(7):672 View
  2. Ahmed S, Loiselle C. Patient Adherence to Oral Anticancer Agents: A Mapping Review of Supportive Interventions. Current Oncology 2023;30(12):10224 View
  3. Lau-Min K, Marini J, Shah N, Pucci D, Blauch A, Cambareri C, Mooney B, Agarwal P, Johnston C, Schumacher R, White K, Gabriel P, Rosin R, Jacobs L, Shulman L. Pilot Study of a Mobile Phone Chatbot for Medication Adherence and Toxicity Management Among Patients With GI Cancers on Capecitabine. JCO Oncology Practice 2024;20(4):483 View
  4. Dang T, Wickramasinghe N, Forkan A, Jayaraman P, Burbury K, O’Callaghan C, Whitechurch A, Schofield P. Co-Design, Development, and Evaluation of a Mobile Solution to Improve Medication Adherence in Cancer: Design Science Research Approach. JMIR Cancer 2024;10:e46979 View